the use of probiotics to prevent and attenuate various gastrointestinal manifestations and improve the immunity of intestinal‐associated lymphoid tissue in HIV infection by modulating epithelial barrier functions and microbiota composition can result in a CD4+ count rise in HIV patients with immunologic failure. The gene discussed is CD4; the disease is HIV infectious disease.